Filter Results:
(8,039)
Show Results For
- All HBS Web
(8,039)
- People (21)
- News (1,663)
- Research (5,031)
- Events (19)
- Multimedia (197)
- Faculty Publications (3,491)
Show Results For
- All HBS Web
(8,039)
- People (21)
- News (1,663)
- Research (5,031)
- Events (19)
- Multimedia (197)
- Faculty Publications (3,491)
- 23 Apr 2019
- Video
X-Cor Therapeutics Final Pitch New Venture Competition 2019 Alumni Track
- 23 Apr 2019
- Video
Nom Pot Final Pitch New Venture Competition 2019 Business Track
- Web
Social Enterprise Track | New Venture Competition
Runner-Up Play Video duration: 1:34 2025 New Venture Competition Winner, Social Enterprise Track: Lexi Lexi is an AI-powered medical interpretation platform that enables... View Details
- Web
Prizes & Benefits | New Venture Competition
encourage more HBS graduates to become involved in social enterprises and to support their efforts. Resources & Benefits The social enterprise track of the student New Venture View Details
- 08 Feb 2022
- Blog Post
Get to Know Past New Venture Competition Winners: Everly Health
With the New Venture Competition (NVC) Finale right around the corner and in celebration of the competition’s 25 years at Harvard Business School, we caught up with some of the... View Details
- 02 May 2014
- Video
Saathi: 2014 New Venture Competition Social Enterprise Track Winner
- 26 Apr 2016
- Video
Cobli wins 2016 Alumni New Venture Competition
- 02 May 2014
- Video
Tomato Jos: 2014 New Venture Competition Social Enterprise Runner-Up
- 23 Apr 2019
- Video
Instagram Takeover - 2019 New Venture Competition
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- 23 Mar 2023
- News
Winners Crowned in 2023 Alumni New Venture Competition
Alumni-founded startups M7 Health and Hue came out victorious in the 2023 Alumni New Venture Competition on Thursday, winning the Grand Prize and Runner Up awards respectively... View Details
- 15 Apr 2020
- Video
Vena Vitals: Runner-up in the 2020 New Venture Competition Alumni Track
- Research Summary
New Venture Growth
Young and no Money? Never Mind: Strategies for New Venture Growth. Being revised (R&R) for Organization Science.
Mukti's dissertation, "Great Oaks from Little Acorns Grow: Strategies for New Venture Growth," explored how intangible resources such... View Details
- Web
Winners & Success Stories | New Venture Competition
Winners & Success Stories The New Venture Competition has been the launching pad for many ventures, and not just from the winning teams. With more than half of Harvard Business... View Details
- 01 Apr 2022
- Video
Collective Runner-Up 2022 New Venture Competition Alumni Track
- 24 Apr 2015
- Video
StreetShares wins Best Investment in HBS Alumni New Venture Competition
- 24 Apr 2019
- Video
Blueland Wins 2019 New Venture Competition Alumni Track
- 25 Apr 2017
- Video